{"id":"W1990473701","doi":"10.1038/sj.clpt.6100345","title":"Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist","year":2007,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Pharmacodynamics; Antagonist; Tolerability; Medicine; Crossover study; Clinical pharmacology; Receptor antagonist; Chemistry; Placebo; Receptor; Adverse effect; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007564822,0.0003894247,0.001131859,0.0002633307,0.0002418694,0.0003938858,0.0002665516,0.0006768145,0.001216222],"category_scores_gemma":[0.001979262,0.0003950834,0.0005178089,0.0002681666,0.0004951518,0.0005195591,0.0001228211,0.001194497,0.000353068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004175346,"about_ca_system_score_gemma":0.0003468096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003760713,"about_ca_topic_score_gemma":0.0004054252,"domain_scores_codex":[0.9994191,0.0002772147,0.00004455349,0.00008513028,0.0001280978,0.00004595404],"domain_scores_gemma":[0.9991417,0.0002592154,0.0002947051,0.00007246186,0.00006024821,0.0001716613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4173619,0.01296887,0.0239136,0.0007805813,0.001824261,0.0006382337,0.0002823197,0.002619329,0.3270907,0.0003362415,0.001630459,0.2105534],"study_design_scores_gemma":[0.06623106,0.6333598,0.1981507,0.00004811565,0.002417987,0.00344771,0.0001391079,0.005313208,0.08554567,0.0003814597,0.004852925,0.0001121138],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949716,0.002720651,0.001027105,0.000094862,0.00002507641,0.0001851809,0.0002649919,0.0000587289,0.0006517278],"genre_scores_gemma":[0.9973562,0.0008716923,0.0007944313,0.0001432552,0.00008133594,0.000137801,0.00027251,0.00001375362,0.0003290438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001216222,"threshold_uncertainty_score":0.004068732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03967373758519056,"score_gpt":0.3898679952633786,"score_spread":0.3501942576781881,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}